Skip to main content
TipRanks
Go Ultimate75% OFF

Marker Therapeutics (GX1) Balance Sheet

1 Followers

Marker Therapeutics Balance Sheet

Marker Therapeutics's total assets for Q2 2026 were $14.59M, a decrease of 16.34% from the previous quarter. DE:GX1 total liabilities were $2.42M for the fiscal quarter, a 33.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Mar 25Dec 23Dec 22Dec 21
$ 19.07M$ 22.02M$ 17.13M$ 34.42M$ 68.14M
$ 2.27M$ 3.46M$ 3.07M$ 14.82M$ 24.15M
$ 16.80M$ 18.56M$ 14.05M$ 19.60M$ 43.99M

Currency in USD

Marker Therapeutics Liabilities to Assets

025M50M75M0 %15 %30 %45 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets